Christopher HanksMedical Director, The Center for Autism Services and Transition 


The Ohio State University Wexner Medical Center
Department of internal Medicine 
General Internal Medicine and Pediatrics at Hilliard 
3691 Ridge Mill Drive
Hilliard, OH 43026

Christopher.Hanks@osumc.edu

614-688-9220


In Internal Medicine and Pediatrics at Hilliard, Dr. Chris Hanks works with patients of all ages, from newborns to elderly.  Dr. Hanks has a specific focus on caring for adults on the autism spectrum and is the Medical director for the Center for Autism Services and Transition (CAST).  In this role, Dr. Hanks works with young adults and adults and he focuses on improving access to care by understanding potential barriers and helping patients navigate the healthcare system.

Currently, he is involved research focused on better understanding the experience of patients on the autism spectrum as they transition from pediatric to adult care as well as ways to overcome the barriers they experience.  He also frequently provides education and training to other healthcare providers to improve their comfort in caring for patients on the autism spectrum.  
 



Education and Training


Chief Medical Resident: Internal Medicine, The Ohio State University 

MD: Penn State University College of Medicine                      
                     
                                                                    
Professional Awards

James N. Allen Housestaff Award for Excellence in Pulmonary Medicine: The Ohio State University Internal Medicine Residency

Resident Teaching Award: Department of Pediatrics, The Ohio State University College of Medicine

Mentor of the Year, 2011: Department of Internal Medicine Student Education Programs, The Ohio State University

Resident Teaching Excellence Award: Department of Internal Medicine Student Education Programs, The Ohio State University 


Abstracts and Peer-Reviewed Journal Articles

Harris L., Gilmore D., Darragh A., Hanks C., Coury D., Moffatt-Bruce S., Garvin J., Hand B.  It was surprisingly equivalent to the appointment I had in person”: Advantages and disadvantages of synchronous telehealth for delivering primary care for autistic adults.  Autism, accepted for publication on Oct 28, 2021.  

Alain, G., Gilmore D., Krantz M., Hanks C., Coury D., Moffatt-Bruce S., Garvin J., Hand B.  Expenditures and Healthcare Utilization of Patients Receiving Care at a Specialized Primary Care Clinic Designed with and for Autistic Adults.  J Gen Int Med, accepted for publication on Sept 9, 2021. 

Hart L., Saha H., Lawrence S., Friedman S., Irwin P., Hanks C.  Implementation and evolution of a primary care-based program for adolescents and young adults on the autism spectrum.  J Autism Dev Disord 2021 Jul 2;1-10, online ahead of print

Hand B., Gilmore D., Harris L., Darragh A., Hanks C., Coury D., Moffatt-Bruce S., Garvin J.  “They looked at me as a person, not just a diagnosis”: A qualitative study of patient and caregiver satisfaction with a specialized primary care clinic for autistic adults.  Accepted for publication in Autism in Adulthood on 23 Apr 2021

Hand B., Gilmore D., Coury D., Darragh A., Moffatt-Bruce S., Hanks C., Garvin J.  Effects of a specialized primary care facility on preventative service use among autistic adults: A retrospective study.  J Gen Int Med 2021 Jun;36(6):1682-1688.

Barnette D., Hanks C., Li W., Porter K.  Patient-level medication regimen complexity in an adolescent and adult population with autism spectrum disorders.  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2018.  Published online 3 Dec 2018. 

Nathawad R., Hanks C.  Optimizing the Office Visit for Adolescents with Special Health Care Needs.  Curr Probl Pediatr Adolesc Health Care 2017;47: 182-189.

Bose-Brill S., Xing J., Barnette D., Hanks C.  Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders.  Pharmacogenomics and Personalized Medicine 2017; 10: 247-252. 

Saqr Y., Braun E., Porter K., Barnette D., Hanks C.  Addressing Medical Needs of Adolescents and Adults with Autism Spectrum Disorders in a Primary Care Setting.  Autism: International Journal of Research and Practice.  2018 Jan; 22(1):51-61.

Bates K., Nourie C.E., Hanks C., and Friedland, A.  Legal Options, Challenges and Insights in Supporting Young Adults with Disabilities.  SGIM Forum 2013; 36(4): 6, 13.  

Bates K., Nourie C.E., Hanks C., and Friedland, A.  “Legal Options, Challenges and Insights in Supporting Young Adults with Disabilities.” SGIM Forum 2013; 36(4): 6, 13. 

Hanks CD., Parsons JP., Benninger C., Kaeding C., Best T., Phillips G., Mastronarde JG. “Etiology of Dyspnea in Elite and Recreational Athletes.”  The Physician and Sportsmedicine 2012 May; 2: 28-33. 
 
Thapliyal A., Bannister R., Hanks C., Adams B.  “The monomeric G proteins AGS1 and Rhes selectively influence Gαi-dependent signaling to modulate N-type (CaV2.2) calcium channels.”  Am J Physiol Cell Physiol 2008 Sept; 295: C1417-C1426. 
 
Santos C.B., Hanks C., McCann J., Lehman E.B., Pratt E., Craig T.J.  “The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence.”  Allergy and Asthma Proceedings 2008 Mar; 29(2): 140-145. 

Santos C.B., Pratt E.L., Hanks C., McCann J., Craig T.J.  “Allergic rhinitis and its effects on sleep, fatigue, and daytime somnolence.”  Ann Allergy Asthma Immunol 2006 Nov; 97(5): 579-86.

Gibbs J., Hanks C., McCann J., et al.  ”Allergic rhinitis and sleep disturbances.”   Otorinolaringol. 2006; 56: 27-35.  

Craig T.J., Hanks C.D., and Fisher L.H. “How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis?”  J Allergy Clin Immunol 2005; 116(6):1264-6.